Fredun Pharmaceuticals Limited (NSE:FREDUN)
India flag India · Delayed Price · Currency is INR
1,390.00
+7.40 (0.54%)
Last updated: Sep 23, 2026, 3:29 PM IST

Fredun Pharmaceuticals Statistics

Total Valuation

NSE:FREDUN has a market cap or net worth of INR 23.08 billion. The enterprise value is 24.85 billion.

Market Cap23.08B
Enterprise Value 24.85B

Important Dates

The next estimated earnings date is Tuesday, November 3, 2026.

Earnings Date Nov 3, 2026
Ex-Dividend Date Jun 23, 2026

Share Statistics

Current Share Class 16.54M
Shares Outstanding n/a
Shares Change (YoY) +25.55%
Shares Change (QoQ) -59.39%
Owned by Insiders (%) 39.08%
Owned by Institutions (%) 3.83%
Float 10.07M

Valuation Ratios

The trailing PE ratio is 59.19.

PE Ratio 59.19
Forward PE n/a
PS Ratio 3.10
PB Ratio 8.30
P/TBV Ratio 8.32
P/FCF Ratio n/a
P/OCF Ratio 193.89
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 63.74
EV / Sales 3.34
EV / EBITDA 23.62
EV / EBIT 25.83
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.87
Debt / EBITDA 2.30
Debt / FCF -3.93
Interest Coverage 2.43

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 14.08%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 8.64%
Revenue Per Employee 10.11M
Profits Per Employee 529,720
Employee Count736
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NSE:FREDUN has paid 195.20 million in taxes.

Income Tax 195.20M
Effective Tax Rate 33.36%

Stock Price Statistics

Beta (5Y) 0.76
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 47.95
Average Volume (20 Days) 62,993

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:FREDUN had revenue of INR 7.44 billion and earned 389.87 million in profits. Earnings per share was 23.48.

Revenue7.44B
Gross Profit 1.82B
Operating Income 961.95M
Pretax Income 585.07M
Net Income 389.87M
EBITDA 1.05B
EBIT 961.95M
Earnings Per Share (EPS) 23.48
Full Income Statement

Balance Sheet

The company has 649.27 million in cash and 2.42 billion in debt, with a net cash position of -1.77 billion.

Cash & Cash Equivalents 649.27M
Total Debt 2.42B
Net Cash -1.77B
Net Cash Per Share n/a
Equity (Book Value) 2.78B
Book Value Per Share 169.39
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 119.02 million and capital expenditures -735.91 million, giving a free cash flow of -616.89 million.

Operating Cash Flow 119.02M
Capital Expenditures -735.91M
Depreciation & Amortization 90.05M
Net Borrowing 552.54M
Free Cash Flow -616.89M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 24.51%, with operating and profit margins of 12.93% and 5.24%.

Gross Margin 24.51%
Operating Margin 12.93%
Pretax Margin 7.87%
Profit Margin 5.24%
EBITDA Margin 14.14%
EBIT Margin 12.93%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 0.05%.

Dividend Per Share 0.70
Dividend Yield 0.05%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -25.55%
Shareholder Yield -25.50%
Earnings Yield 1.69%
FCF Yield -2.67%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2